Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 January 2018 Photo Charl Devenish
UFS researcher publishes the highest-cited Maths paper in the world in 2017
An article by Prof Abdon Atangana from the University of the Free State’s Institute for Groundwater Studies received New Hot Paper status from Clarivate Analytics.

An article on Applied Mathematics, published by Prof Abdon Atangana from the University of the Free State’s Institute for Groundwater Studies in 2017, was recently named New Hot Paper by Clarivate Analytics.

Hot paper status
Essential Science Indicators (ESI) is a unique and comprehensive compilation of science performance statistics and science trends. Data is based on journal article publication counts and citation data from Clarivate Analytics that enables researchers to conduct ongoing, quantitative analyses of research performance and track trends in science. Covering a multidisciplinary selection of 1 2000+ journals from around the world, this in-depth analytical tool offers data for ranking papers, scientists, institutions, countries, and journals. 

ESI from Clarivate Analytics is updated every two months. The New Hot Papers, which are papers published in the past two years, are in the top one-tenth of one percent (0.1%) for their field and publication period. Prof Atangana’s paper had the highest cite count in the field of Mathematics. 

His article that received the New Hot Paper status is titled: “The new fractional derivative and application to nonlinear Fisher’s reaction-diffusion equation”.

The concept of fractional differential operators with non-singular kernel has captured the minds of several researchers in the past year due to their wider applicability in almost all fields of science, engineering and technology. The new fractional differential operators have opened new windows to model complex real-world problems that could not be modelled using the Newtonian and the well-known Riemann-Liouville fractional differential operators. 

“These operators are the way forward in modelling real-world problems in all disciplines, as they are able to include into mathematical formulation the effect of memory,” Prof Atangana said.

The Atangana-Baleanu fractional derivative
The professor developed a new fractional differential operator, called the Atangana-Baleanu fractional derivative. This derivative is able to describe real-world problems with different scales or problems that change their properties during time and space, for instance, the spread of cancer; the flow of water within heterogeneous aquifers, movement of pollution within fractured aquifers and many others.”

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept